Association between environmental tobacco smoke exposure and wheezing disorders in Austrian preschool children

Elisabeth Horak1, Bernhard Morass, Hanno Ulmer

  • 1Department of Pediatrics and Adolescents, Division of Pediatric Cardiology and Pulmonology, Innsbruck Medical University, Innsbruck, Austria. Elisabeth.Horak@uki.at

Swiss Medical Weekly
|November 9, 2007
PubMed

Insights

Prenatal exposure to environmental tobacco smoke (ETS) significantly increases the risk of wheezing and asthma in preschool children. Children exposed to ETS also have poorer nutrition, including less breastfeeding and lower fruit/vegetable intake.

Area of Science:

  • Pediatric Environmental Health
  • Respiratory Medicine
  • Allergy and Immunology

Background:

  • Passive smoking, or environmental tobacco smoke (ETS) exposure, poses significant health risks, particularly to vulnerable populations like fetuses and young children.
  • Previous research indicates a strong impact of ETS on early life development, necessitating further investigation into specific disorders.
  • Atopic and wheezing disorders are common in childhood and may be influenced by environmental factors such as ETS.

Purpose of the Study:

  • To investigate the effect of environmental tobacco smoke (ETS) exposure on atopic and wheezing disorders in Austrian preschool children.
  • To assess the association between prenatal ETS exposure and the development of wheezing and asthma.
  • To explore the relationship between ETS exposure and lifestyle factors like breastfeeding and diet in preschool children.

Main Methods:

  • A cross-sectional questionnaire survey was conducted among 1737 Austrian preschool children.
  • Data collected included information on passive smoking exposure (ETS) and the prevalence of wheezy bronchitis, asthma, hay fever, and atopic dermatitis.
  • Statistical analysis was performed to determine the odds ratios (OR) and confidence intervals (CI) for the association between ETS exposure and health outcomes.

Main Results:

  • Up to 46% of children were exposed to ETS, with higher risk observed in those from lower socioeconomic backgrounds.
  • Prenatal ETS exposure was significantly linked to an increased risk of wheezing in the first year of life (OR 1.6) and past 12 months (OR 1.5).
  • Doctor-diagnosed asthma risk was significantly higher in children with prenatal ETS exposure (OR 2.1), and smoking families reported less breastfeeding and lower fruit/vegetable consumption.

Conclusions:

  • Prenatal environmental tobacco smoke (ETS) exposure is a confirmed risk factor for wheezing and asthma in preschool children.
  • Children exposed to ETS exhibit less healthy lifestyle patterns, including reduced breastfeeding and lower intake of fruits and vegetables.
  • The combination of ETS exposure and poor nutrition raises concerns about increased oxidative stress and long-term health in affected children.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.2K